Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Extended-release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living with HIV and Alcohol use Disorders Transitioning to the Community: Results From a Double-Blind, Placebo-Controlled Trial
Sandra A. Springer, Angela Di Paola, Russell Barbour, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2018) Vol. 79, Iss. 1, pp. 92-100
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
Rajesh T. Gandhi, Roger Bedimo, Jennifer Hoy, et al.
JAMA (2022) Vol. 329, Iss. 1, pp. 63-63
Closed Access | Times Cited: 362
Medications for Treatment of Opioid Use Disorder among Persons Living with HIV
Laura Fanucchi, Sandra A. Springer, P. Todd Korthuis
Current HIV/AIDS Reports (2019) Vol. 16, Iss. 1, pp. 1-6
Open Access | Times Cited: 60
Infectious Complications of Addiction: A Call for a New Subspecialty Within Infectious Diseases
David P. Serota, Joshua A. Barocas, Sandra A. Springer
Clinical Infectious Diseases (2019) Vol. 70, Iss. 5, pp. 968-972
Open Access | Times Cited: 52
Efficacy and safety of alcohol reduction pharmacotherapy according to treatment duration in patients with alcohol dependence or alcohol use disorder: A systematic review and network meta‐analysis
Kazumasa Kotake, Tomonari Hosokawa, Masuo Tanaka, et al.
Addiction (2024) Vol. 119, Iss. 5, pp. 815-832
Closed Access | Times Cited: 4
Prescribing methadone in prison predicts linkage to HIV care after release from prison: A randomized and patient preference trial
Allison Mobley, Martin Wegman, Alexander R. Bazazi, et al.
International Journal of Drug Policy (2025) Vol. 137, pp. 104733-104733
Closed Access
A Literature Review Examining Primary Outcomes of Medication Treatment Studies for Opioid Use Disorder: What Outcome Should Be Used to Measure Opioid Treatment Success?
Breanne E. Biondi, Xiaoying Zheng, Cynthia Frank, et al.
American Journal on Addictions (2020) Vol. 29, Iss. 4, pp. 249-267
Open Access | Times Cited: 29
Preventing HIV outbreaks among people who inject drugs in the United States: plus ça change, plus ça même chose
Steffanie A. Strathdee, Irene Kuo, Nabila El‐Bassel, et al.
AIDS (2020) Vol. 34, Iss. 14, pp. 1997-2005
Open Access | Times Cited: 29
Integrated Care Models: HIV and Substance Use
Katherine Hill, Irene Kuo, Sheela Shenoi, et al.
Current HIV/AIDS Reports (2023) Vol. 20, Iss. 5, pp. 286-295
Open Access | Times Cited: 9
Opportunities to Offer Harm Reduction to People who Inject Drugs During Infectious Disease Encounters: Narrative Review
Alyssa M. Peckham, Erika Young
Open Forum Infectious Diseases (2020) Vol. 7, Iss. 11
Open Access | Times Cited: 27
Interventions to Improve HIV Care Continuum Outcomes Among Individuals Released From Prison or Jail: Systematic Literature Review
Daniel M. Woznica, Nimasha B. Fernando, Elizabeth Bonomo, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2020) Vol. 86, Iss. 3, pp. 271-285
Open Access | Times Cited: 26
Challenges of reaching 90–90–90 in the Southern United States
Jonathan Colasanti, Wendy S. Armstrong
Current Opinion in HIV and AIDS (2019) Vol. 14, Iss. 6, pp. 471-480
Closed Access | Times Cited: 24
Reduction in Drinking was Associated With Improved Clinical Outcomes in Women With HIV Infection and Unhealthy Alcohol Use: Results From a Randomized Clinical Trial of Oral Naltrexone Versus Placebo
Robert L. Cook, Zhi Zhou, María José Míguez, et al.
Alcoholism Clinical and Experimental Research (2019) Vol. 43, Iss. 8, pp. 1790-1800
Open Access | Times Cited: 23
Endogenous Opiates and Behavior: 2018
Richard J. Bodnar
Peptides (2020) Vol. 132, pp. 170348-170348
Closed Access | Times Cited: 21
HIV clinic-based buprenorphine plus naloxone versus referral for methadone maintenance therapy for treatment of opioid use disorder in HIV clinics in Vietnam (BRAVO): an open-label, randomised, non-inferiority trial
P. Todd Korthuis, Caroline King, Ryan Cook, et al.
The Lancet HIV (2021) Vol. 8, Iss. 2, pp. e67-e76
Open Access | Times Cited: 19
Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV
Benjamin J. Oldfield, Kathleen A. McGinnis, E. Jennifer Edelman, et al.
Journal of Substance Abuse Treatment (2019) Vol. 109, pp. 14-22
Open Access | Times Cited: 22
Study protocol of a randomized controlled trial comparing two linkage models for HIV prevention and treatment in justice-involved persons
Sandra A. Springer, Ank E. Nijhawan, Kevin Knight, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Interventions Designed to Improve HIV Continuum of Care Outcomes for Persons with HIV in Contact with the Carceral System in the USA
Emily Dauria, Priyanka Kulkarni, Angelo Clemenzi-Allen, et al.
Current HIV/AIDS Reports (2022) Vol. 19, Iss. 4, pp. 281-291
Open Access | Times Cited: 12
Methamphetamine use drives decreases in viral suppression for people living with HIV released from a large municipal jail: Results of the LINK LA clinical trial
David Goodman‐Meza, Steven Shoptaw, Robert E. Weiss, et al.
Drug and Alcohol Dependence (2019) Vol. 202, pp. 178-184
Open Access | Times Cited: 18
Optimizing HIV prevention and treatment outcomes for persons with substance use in Central Asia
Anna Deryabina, Wafaa El‐Sadr
Current Opinion in HIV and AIDS (2019) Vol. 14, Iss. 5, pp. 374-380
Open Access | Times Cited: 17
A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail
Michael Gordon, Shannon Gwin Mitchell, Thomas R. Blue, et al.
Journal of Substance Abuse Treatment (2020) Vol. 128, pp. 108241-108241
Open Access | Times Cited: 15
Medications for Opioid Use Disorder Among Incarcerated Individuals: a Review of the Literature and Focus on Patient Preference
Lisa B. Puglisi, Precious Bedell, Anna Steiner, et al.
Current Addiction Reports (2019) Vol. 6, Iss. 4, pp. 365-373
Closed Access | Times Cited: 12
Co-located Opioid Use Disorder and Hepatitis C Virus Treatment Is Not Only Right, But It Is Also the Smart Thing To Do as It Improves Outcomes!
Sandra A. Springer, Carlos del Rı́o
Clinical Infectious Diseases (2020) Vol. 71, Iss. 7, pp. 1723-1725
Open Access | Times Cited: 12
Changing Patterns of Alcohol Use and Probability of Unsuppressed Viral Load Among Treated Patients with HIV Engaged in Routine Care in the United States
Catherine R. Lesko, Robin M. Nance, Bryan Lau, et al.
AIDS and Behavior (2020) Vol. 25, Iss. 4, pp. 1072-1082
Open Access | Times Cited: 12
A randomized control trial of a combined community health worker and re-entry intervention for people with HIV recently released from jail who use substances
Emily Hoff, Laura Hansen, Zoe Pulitzer, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 152, pp. 209118-209118
Closed Access | Times Cited: 4
Considerations for long-acting antiretroviral therapy in older persons with HIV
Jesse O’Shea, Preetam Cholli, Emily L. Heil, et al.
AIDS (2023) Vol. 37, Iss. 15, pp. 2271-2286
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top